The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
Deubiquitinases in cancer: new functions and therapeutic options
Open accessAbstract
Deubiquitinases (DUBs) have fundamental roles in the ubiquitin system through their ability to specifically deconjugate ubiquitin from targeted proteins. The human genome encodes at least 98 DUBs, which can be grouped into 6 families, reflecting the need for specificity in their function. The activity of these enzymes affects the turnover rate, activation, recycling and localization of multiple proteins, which in turn is essential for cell homeostasis, protein stability and a wide range of signaling pathways. Consistent with this, altered DUB function has been related to several diseases, including cancer. Thus, multiple DUBs have been classified as oncogenes or tumor suppressors because of their regulatory functions on the activity of other proteins involved in tumor development. Therefore, recent studies have focused on pharmacological intervention on DUB activity as a rationale to search for novel anticancer drugs. This strategy may benefit from our current knowledge of the physiological regulatory mechanisms of these enzymes and the fact that growth of several tumors depends on the normal activity of certain DUBs. Further understanding of these processes may provide answers to multiple remaining questions on DUB functions and lead to the development of DUB-targeting strategies to expand the repertoire of molecular therapies against cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ubiquitin‐specific protease 4 is inhibited by its ubiquitin‐like domain
Luna‐Vargas, M. P. A., Faesen, A. C., van Dijk, W. J., Rapé, M., Fish, A., & Sixma, T. K. (2011) · EMBO Reports · doi:10.1038/embor.2011.33 · Cited by 45
RetractedCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278
Breaking the chains: structure and function of the deubiquitinases
Komander, D., Clague, M. J., & Urbé, S. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2731 · Cited by 1,969
The p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
Harbour, J. W., Onken, M. D., Roberson, E. D. O., Duan, S., Cao, L., Worley, L. A., Council, M. L., Matatall, K. A., Helms, C., & Bowcock, A. M. (2010) · Science · doi:10.1126/science.1194472 · Cited by 1,462
Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.
Reyes-Turcu, F. E., Ventii, K. H., & Wilkinson, K. D. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082307.091526 · Cited by 1,396
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
Targeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
Hershko, A., Heller, H., Elias, S., & Ciechanover, A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82050-x · Cited by 1,160
Proteases: Multifunctional Enzymes in Life and Disease
López-Otín, C., & Bond, J. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800035200 · Cited by 1,144
Self-citationMutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,069
Mechanism and function of deubiquitinating enzymes
Amerik, A. Y., & Hochstrasser, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.10.003 · Cited by 974
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 952
Human and mouse proteases: a comparative genomic approach
Puente, X. S., Sánchez, L. M., Overall, C. M., & López-Otín, C. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1111 · Cited by 943
Self-citationEnhancement of proteasome activity by a small-molecule inhibitor of USP14
Lee, B.-H., Lee, M. J., Park, S., Oh, D.-C., Elsasser, S., Chen, P.-C., Gartner, C., Dimova, N., Hanna, J., Gygi, S. P., et al. (2010) · Nature · doi:10.1038/nature09299 · Cited by 893
Atypical ubiquitin chains: new molecular signals
Ikeda, F., & Dikic, I. (2008) · EMBO reports · doi:10.1038/embor.2008.93 · Cited by 825
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
Hartwell, L. H., Szankasi, P., Roberts, C. J., Murray, A. W., & Friend, S. H. (1997) · Science · doi:10.1126/science.278.5340.1064 · Cited by 773
Jensen, D. E., Proctor, M., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201861 · Cited by 723
Derailed endocytosis: an emerging feature of cancer
Mosesson, Y., Mills, G. B., & Yarden, Y. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2521 · Cited by 718
Bott, M., Brevet, M., Taylor, B. S., Shimizu, S., Ito, T., Wang, L., Creaney, J., Lake, R. A., Zakowski, M. F., Reva, B., et al. (2011) · Nature Genetics · doi:10.1038/ng.855 · Cited by 717
Protease degradomics: A new challenge for proteomics
López-Otín, C., & Overall, C. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm858 · Cited by 664
Self-citationHu, M., Li, P., Li, M., Li, W., Yao, T., Wu, J.-W., Gu, W., Cohen, R. E., & Shi, Y. (2002) · Cell · doi:10.1016/s0092-8674(02)01199-6 · Cited by 642
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Yuan, J., Luo, K., Zhang, L., Cheville, J. C., & Lou, Z. (2010) · Cell · doi:10.1016/j.cell.2009.12.032 · Cited by 637 · cited 4×
“Other studies have reported a similar role for USP2 in the stabilization of MDM2, although this DUB, unlike USP7, does not deubiquitylate p53 (Stevenson et al., 2007).”
BackgroundInfluentialDeubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O’Rourke, K., Bazan, F., Eastham-Anderson, J., et al. (2010) · Nature · doi:10.1038/nature08646 · Cited by 628
Emerging principles in protease-based drug discovery
Drag, M., & Salvesen, G. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3053 · Cited by 601
The Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway
Nijman, S. M. B., Huang, T. T., Dirac, A. M. G., Brummelkamp, T. R., Kerkhoven, R. M., D'Andrea, A. D., & Bernards, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.008 · Cited by 588
Regulation of monoubiquitinated PCNA by DUB autocleavage
Huang, T. T., Nijman, S. M. B., Mirchandani, K. D., Galardy, P. J., Cohn, M. A., Haas, W., Gygi, S. P., Ploegh, H. L., Bernards, R., & D'Andrea, A. D. (2006) · Nature Cell Biology · doi:10.1038/ncb1378 · Cited by 581
Regulation of ubiquitin‐dependent processes by deubiquitinating enzymes
Wilkinson, K. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.14.9409543 · Cited by 577
Molecular discrimination of structurally equivalent Lys 63‐linked and linear polyubiquitin chains
Komander, D., Reyes‐Turcu, F., Licchesi, J. D. F., Odenwaelder, P., Wilkinson, K. D., & Barford, D. (2009) · EMBO reports · doi:10.1038/embor.2009.55 · Cited by 572
Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets
Bedford, L., Lowe, J., Dick, L. R., Mayer, R. J., & Brownell, J. E. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3321 · Cited by 563 · cited 1×
“Accordingly, several members of the JAMM metalloprotease family of DUBs, such as POH1, CSN5, AMSH and BRCC36, have been proposed as alternative candidates for drug targeting in cancer (Bedford et al., 2011).”
BackgroundProteolytic networks in cancer
Mason, S. D., & Joyce, J. A. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.12.002 · Cited by 552
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07290 · Cited by 548
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
Pardali, K., & Moustakas, A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.004 · Cited by 526
FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination
Dupont, S., Mamidi, A., Cordenonsi, M., Montagner, M., Zacchigna, L., Adorno, M., Martello, G., Stinchfield, M. J., Soligo, S., Morsut, L., et al. (2009) · Cell · doi:10.1016/j.cell.2008.10.051 · Cited by 494
FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP
van der Horst, A., de Vries-Smits, A. M. M., Brenkman, A. B., van Triest, M. H., van den Broek, N., Colland, F., Maurice, M. M., & Burgering, B. M. T. (2006) · Nature Cell Biology · doi:10.1038/ncb1469 · Cited by 477
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., & Fässler, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.041 · Cited by 476
The ubiquitin-specific protease USP28 is required for MYC stability
Popov, N., Wanzel, M., Madiredjo, M., Zhang, D., Beijersbergen, R., Bernards, R., Moll, R., Elledge, S. J., & Eilers, M. (2007) · Nature Cell Biology · doi:10.1038/ncb1601 · Cited by 474
Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death
Vucic, D., Dixit, V. M., & Wertz, I. E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3143 · Cited by 444
Coornaert, B., Baens, M., Heyninck, K., Bekaert, T., Haegman, M., Staal, J., Sun, L., Chen, Z. J., Marynen, P., & Beyaert, R. (2008) · Nature Immunology · doi:10.1038/ni1561 · Cited by 434
Structure and mechanisms of the proteasome‐associated deubiquitinating enzyme USP14
Hu, M., Li, P., Song, L., Jeffrey, P. D., Chernova, T. A., Wilkinson, K. D., Cohen, R. E., & Shi, Y. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600832 · Cited by 429
Zhang, X.-Y., Varthi, M., Sykes, S. M., Phillips, C., Warzecha, C., Zhu, W., Wyce, A., Thorne, A. W., Berger, S. L., & McMahon, S. B. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.015 · Cited by 427 · cited 1×
“MYSM1, USP7, USP22 and BRCC36 are part of the 2A-DUB, polycomb-repressive complex 1, SAGA and BRCA1-A multisubunit complexes, respectively (Zhu et al., 2007a; Zhang et al., 2008; Feng et al., 2010; Maertens et al., 2010).”
BackgroundTranscriptional regulation by histone ubiquitination and deubiquitination
Zhang, Y. (2003) · Genes & Development · doi:10.1101/gad.1156403 · Cited by 425
NF-κB and cancer: how intimate is this relationship
Prasad, S., Ravindran, J., & Aggarwal, B. B. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0267-2 · Cited by 385
Kapuria, V., Peterson, L. F., Fang, D., Bornmann, W. G., Talpaz, M., & Donato, N. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1530 · Cited by 383
Burnett, B. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg344 · Cited by 373
AMSH is an endosome-associated ubiquitin isopeptidase
McCullough, J., Clague, M. J., & Urbé, S. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200401141 · Cited by 369
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
Graner, E., Tang, D., Rossi, S., Baron, A., Migita, T., Weinstein, L. J., Lechpammer, M., Huesken, D., Zimmermann, J., Signoretti, S., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00055-8 · Cited by 367
Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities
Stegmeier, F., Rape, M., Draviam, V. M., Nalepa, G., Sowa, M. E., Ang, X. L., McDonald III, E. R., Li, M. Z., Hannon, G. J., Sorger, P. K., et al. (2007) · Nature · doi:10.1038/nature05694 · Cited by 367
Non-Oncogene Addiction and the Stress Phenotype of Cancer Cells
Solimini, N. L., Luo, J., & Elledge, S. J. (2007) · Cell · doi:10.1016/j.cell.2007.09.007 · Cited by 365
Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains
Sato, Y., Yoshikawa, A., Yamagata, A., Mimura, H., Yamashita, M., Ookata, K., Nureki, O., Iwai, K., Komada, M., & Fukai, S. (2008) · Nature · doi:10.1038/nature07254 · Cited by 339
Bremm, A., Freund, S. M. V., & Komander, D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1873 · Cited by 332
A Role for the Deubiquitinating Enzyme USP28 in Control of the DNA-Damage Response
Zhang, D., Zaugg, K., Mak, T. W., & Elledge, S. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.039 · Cited by 326
Zhu, P., Zhou, W., Wang, J., Puc, J., Ohgi, K. A., Erdjument-Bromage, H., Tempst, P., Glass, C. K., & Rosenfeld, M. G. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.024 · Cited by 321
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Colland, F., Formstecher, E., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., Trouplin, V., Bianchi, J., Aushev, V. N., Camonis, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0097 · Cited by 321
'Protein Modifications: Beyond the Usual Suspects' Review Series
Ikeda, F., & Đikić, I. (2008) · Cited by 316
USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst
Oliveira, A. M., Hsi, B.-L., Weremowicz, S., Rosenberg, A. E., Cin, P. D., Joseph, N., Bridge, J. A., Perez-Atayde, A. R., & Fletcher, J. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2827 · Cited by 313
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Honma, K., Tsuzuki, S., Nakagawa, M., Tagawa, H., Nakamura, S., Morishima, Y., & Seto, M. (2009) · Blood · doi:10.1182/blood-2008-12-194852 · Cited by 305
Proteasome inhibitors in cancer therapy
Crawford, L. J., Walker, B., & Irvine, A. E. (2011) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-011-0121-7 · Cited by 299
MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling
Liang, J., Saad, Y., Lei, T., Wang, J., Qi, D., Yang, Q., Kolattukudy, P. E., & Fu, M. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092641 · Cited by 297
Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase
Virdee, S., Ye, Y., Nguyen, D. P., Komander, D., & Chin, J. W. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.426 · Cited by 296
Regulation of cell cycle progression and gene expression by H2A deubiquitination
Joo, H.-Y., Zhai, L., Yang, C., Nie, S., Erdjument-Bromage, H., Tempst, P., Chang, C., & Wang, H. (2007) · Nature · doi:10.1038/nature06256 · Cited by 286
Makarova, K. S., Aravind, L., & Koonin, E. V. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01530-3 · Cited by 282
The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2
Stevenson, L. F., Sparks, A., Allende‐Vega, N., Xirodimas, D. P., Lane, D. P., & Saville, M. K. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601567 · Cited by 280
Komander, D., Lord, C. J., Scheel, H., Swift, S., Hofmann, K., Ashworth, A., & Barford, D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.018 · Cited by 276
Otubains: a new family of cysteine proteases in the ubiquitin pathway
Balakirev, M. Y., Tcherniuk, S. O., Jaquinod, M., & Chroboczek, J. (2003) · EMBO reports · doi:10.1038/sj.embor.embor824 · Cited by 275
Yu, H., Mashtalir, N., Daou, S., Hammond-Martel, I., Ross, J., Sui, G., Hart, G. W., Rauscher, F. J., Drobetsky, E., Milot, E., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00396-10 · Cited by 270
Winborn, B. J., Travis, S. M., Todi, S. V., Scaglione, K. M., Xu, P., Williams, A. J., Cohen, R. E., Peng, J., & Paulson, H. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803692200 · Cited by 263
Harnessing synthetic lethal interactions in anticancer drug discovery
Chan, D. A., & Giaccia, A. J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3374 · Cited by 262
Deubiquitinases in the regulation of NF-κB signaling
Harhaj, E. W., & Dixit, V. M. (2011) · Cell Research · doi:10.1038/cr.2010.166 · Cited by 261
Hussain, S., Zhang, Y., & Galardy, P. (2009) · Cell Cycle · doi:10.4161/cc.8.11.8739 · Cited by 260
Liu, Y., Lashuel, H. A., Choi, S., Xing, X., Case, A., Ni, J., Yeh, L.-A., Cuny, G. D., Stein, R. L., & Lansbury, P. T. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.08.010 · Cited by 256
Reiley, W. W., Jin, W., Lee, A. J., Wright, A., Wu, X., Tewalt, E. F., Leonard, T. O., Norbury, C. C., Fitzpatrick, L., Zhang, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062694 · Cited by 254
A20: from ubiquitin editing to tumour suppression
Hymowitz, S. G., & Wertz, I. E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2775 · Cited by 247
Novak, U., Rinaldi, A., Kwee, I., Nandula, S. V., Rancoita, P. M. V., Compagno, M., Cerri, M., Rossi, D., Murty, V. V., Zucca, E., et al. (2009) · Blood · doi:10.1182/blood-2008-08-174110 · Cited by 246
Zhang, J., Stirling, B., Temmerman, S. T., Ma, C. A., Fuss, I. J., Derry, J. M. J., & Jain, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28746 · Cited by 245
The regulatory crosstalk between kinases and proteases in cancer
López-Otín, C., & Hunter, T. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2823 · Cited by 244
Self-citationClague, M. J., & Urbé, S. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.09.002 · Cited by 244
Mechanism and Consequences for Paralog-Specific Sumoylation of Ubiquitin-Specific Protease 25
Meulmeester, E., Kunze, M., Hsiao, H. H., Urlaub, H., & Melchior, F. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.021 · Cited by 238
Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases
Quesada, V., Dı́az-Perales, A., Gutiérrez-Fernández, A., Garabaya, C., Cal, S., & López-Otı́n, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.050 · Cited by 234
Self-citationSuppression of Cancer Cell Growth by Promoting Cyclin D1 Degradation
Shan, J., Zhao, W., & Gu, W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.018 · Cited by 229
Control of AMPK-related kinases by USP9X and atypical Lys29/Lys33-linked polyubiquitin chains
Al-Hakim, A. K., Zagorska, A., Chapman, L., Deak, M., Peggie, M., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20080067 · Cited by 226
Cooper, E. M., Cutcliffe, C., Kristiansen, T. Z., Pandey, A., Pickart, C. M., & Cohen, R. E. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.27 · Cited by 223
The ubiquitous role of ubiquitin in the DNA damage response
Al-Hakim, A., Escribano-Diaz, C., Landry, M.-C., O’Donnell, L., Panier, S., Szilard, R. K., & Durocher, D. (2010) · DNA Repair · doi:10.1016/j.dnarep.2010.09.011 · Cited by 223
Koulich, E., Li, X., & DeMartino, G. N. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-10-1040 · Cited by 223
T‐cell receptor‐induced JNK activation requires proteolytic inactivation of CYLD by MALT1
Staal, J., Driege, Y., Bekaert, T., Demeyer, A., Muyllaert, D., Van Damme, P., Gevaert, K., & Beyaert, R. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.85 · Cited by 219
Tauriello, D. V. F., Haegebarth, A., Kuper, I., Edelmann, M. J., Henraat, M., Canninga-van Dijk, M. R., Kessler, B. M., Clevers, H., & Maurice, M. M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.035 · Cited by 217
The 26 S Proteasome: From Basic Mechanisms to Drug Targeting
Navon, A., & Ciechanover, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.018481 · Cited by 214
NF-κB Suppression by the Deubiquitinating Enzyme Cezanne
Enesa, K., Zakkar, M., Chaudhury, H., Luong, L. A., Rawlinson, L., Mason, J. C., Haskard, D. O., Dean, J. L. E., & Evans, P. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708690200 · Cited by 213
Mechanisms, biology and inhibitors of deubiquitinating enzymes
Love, K. R., Catic, A., Schlieker, C., & Ploegh, H. L. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.43 · Cited by 210
Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma
Massoumi, R., Kuphal, S., Hellerbrand, C., Haas, B., Wild, P., Spruss, T., Pfeifer, A., Fässler, R., & Bosserhoff, A. K. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082044 · Cited by 209
Niendorf, S., Oksche, A., Kisser, A., Löhler, J., Prinz, M., Schorle, H., Feller, S., Lewitzky, M., Horak, I., & Knobeloch, K.-P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01566-06 · Cited by 207
Dayal, S., Sparks, A., Jacob, J., Allende-Vega, N., Lane, D. P., & Saville, M. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805871200 · Cited by 199
Yoshida, H., Jono, H., Kai, H., & Li, J.-D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509526200 · Cited by 199
CSN controls NF‐κB by deubiquitinylation of IκBα
Schweitzer, K., Bozko, P. M., Dubiel, W., & Naumann, M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601600 · Cited by 197
VHL protein‐interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF‐1α
Li, Z., Wang, D., Messing, E. M., & Wu, G. (2005) · EMBO reports · doi:10.1038/sj.embor.7400377 · Cited by 196
A Genomic Analysis of Rat Proteases and Protease Inhibitors
Puente, X. S., & López-Otín, C. (2004) · Genome Research · doi:10.1101/gr.1946304 · Cited by 192
Self-citationNicastro, G., Menon, R. P., Masino, L., Knowles, P. P., McDonald, N. Q., & Pastore, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501732102 · Cited by 188
Ubiquitin carboxyl-terminal hydrolase acts on ubiquitin carboxyl-terminal amides.
Pickart, C. M., & Rose, I. A. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39538-8 · Cited by 187
Protein partners of deubiquitinating enzymes
Ventii, K. H., & Wilkinson, K. D. (2008) · Biochemical Journal · doi:10.1042/bj20080798 · Cited by 185
Dammer, E. B., Na, C. H., Xu, P., Seyfried, N. T., Duong, D. M., Cheng, D., Gearing, M., Rees, H., Lah, J. J., Levey, A. I., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149633 · Cited by 184
The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-β signalling
Wicks, S. J., Haros, K., Maillard, M., Song, L., Cohen, R. E., Dijke, P. T., & Chantry, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208944 · Cited by 183
ABINs: A20 binding inhibitors of NF-κB and apoptosis signaling
Verstrepen, L., Carpentier, I., Verhelst, K., & Beyaert, R. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.02.009 · Cited by 180
Gcn5 and SAGA Regulate Shelterin Protein Turnover and Telomere Maintenance
Atanassov, B. S., Evrard, Y. A., Multani, A. S., Zhang, Z., Tora, L., Devys, D., Chang, S., & Dent, S. Y. R. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.015 · Cited by 180
Nakamura, N., & Hirose, S. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-11-1103 · Cited by 179
Inactivation of HAUSP in vivo modulates p53 function.
Kon, N., Kobayashi, Y., Li, M., Brooks, C. L., Ludwig, T., & Gu, W. (2010) · Oncogene · doi:10.1038/onc.2009.427 · Cited by 176
The Degradome database: mammalian proteases and diseases of proteolysis
Quesada, V., Ordonez, G. R., Sanchez, L. M., Puente, X. S., & Lopez-Otin, C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn570 · Cited by 172
Self-citationUbiquitination directly enhances activity of the deubiquitinating enzyme ataxin‐3
Todi, S. V., Winborn, B. J., Scaglione, K. M., Blount, J. R., Travis, S. M., & Paulson, H. L. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.289 · Cited by 171
Deubiquitinase USP37 Is Activated by CDK2 to Antagonize APCCDH1 and Promote S Phase Entry
Huang, X., Summers, M. K., Pham, V. C., Lill, J. R., Liu, J., Lee, G., Kirkpatrick, D. S., Jackson, P. K., Fang, G., & Dixit, V. M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.027 · Cited by 166
Ubiquitin‐specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor
Maertens, G. N., Messaoudi, S. E., Elderkin, S., Hiom, K. J., & Peters, G. G. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.129 · Cited by 165
Reduced expression of CYLD in human colon and hepatocellular carcinomas
Hellerbrand, C., Bumes, E., Bataille, F., Dietmaier, W., Massoumi, R., & Bosserhoff, A. K. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl081 · Cited by 165
Deubiquitinating function of ataxin-3: Insights from the solution structure of the Josephin domain
Mao, Y., Senic-Matuglia, F., Di Fiore, P. P., Polo, S., Hodsdon, M. E., & De Camilli, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506344102 · Cited by 162
Complementary Roles for Rpn11 and Ubp6 in Deubiquitination and Proteolysis by the Proteasome
Guterman, A., & Glickman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307050200 · Cited by 161
Schoenfeld, A. R., Apgar, S., Dolios, G., Wang, R., & Aaronson, S. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7444-7455.2004 · Cited by 160
Li, Z., Na, X., Wang, D., Schoen, S. R., Messing, E. M., & Wu, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108269200 · Cited by 159
USP4 inhibits p53 through deubiquitinating and stabilizing ARF‐BP1
Zhang, X., Berger, F. G., Yang, J., & Lu, X. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.125 · Cited by 158
USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation
Fan, Y.-H., Yu, Y., Mao, R.-F., Tan, X.-J., Xu, G.-F., Zhang, H., Lu, X.-B., Fu, S.-B., & Yang, J. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.11 · Cited by 158
Yao, T., Song, L., Jin, J., Cai, Y., Takahashi, H., Swanson, S. K., Washburn, M. P., Florens, L. A., Conaway, R., Cohen, R. E., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.027 · Cited by 158
Yu, J. Q., Tao, Q., Cheung, K. F., Jin, H., Poon, F. F., Wang, X., Li, H., Cheng, Y. Y., Röcken, C., Ebert, M. P. A., et al. (2008) · Hepatology · doi:10.1002/hep.22343 · Cited by 154
Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD
Reiley, W. W., Zhang, M., & Sun, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411049200 · Cited by 152
The Isopeptidase USP2a Protects Human Prostate Cancer from Apoptosis
Priolo, C., Tang, D., Brahamandan, M., Benassi, B., Sicińska, E., Ogino, S., Farsetti, A., Porrello, A., Finn, S. P., Zimmermann, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1374 · Cited by 152
Nagai, H., Noguchi, T., Homma, K., Katagiri, K., Takeda, K., Matsuzawa, A., & Ichijo, H. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.016 · Cited by 147
The p53–Mdm2–HAUSP complex is involved in p53 stabilization by HAUSP
Brooks, C. L., Li, M., Hu, M., Shi, Y., & Gu, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210531 · Cited by 147
The Ubiquitin-Specific Protease USP34 Regulates Axin Stability and Wnt/β-Catenin Signaling
Lui, T. T. H., Lacroix, C., Ahmed, S. M., Goldenberg, S. J., Leach, C. A., Daulat, A. M., & Angers, S. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01094-10 · Cited by 147
Hussain, S., Foreman, O., Perkins, S. L., Witzig, T. E., Miles, R. R., van Deursen, J., & Galardy, P. J. (2010) · Leukemia · doi:10.1038/leu.2010.138 · Cited by 145
Jenner, M. W., Leone, P., Walker, B. A., Ross, F. M., Johnson, D. C., de Castro, D. G., Chiecchio, L., Cabanas, E. D., Dagrada, G. P., Nightingale, M., et al. (2007) · Blood · doi:10.1182/blood-2007-02-075069 · Cited by 143
Liu, J., Chung, H., Vogt, M., Jin, Y., Malide, D., He, L., Dundr, M., & Levens, D. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.11 · Cited by 141
UBPY-mediated Epidermal Growth Factor Receptor (EGFR) De-ubiquitination Promotes EGFR Degradation
Alwan, H. A. J., & van Leeuwen, J. E. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m604711200 · Cited by 140
The tumor suppressor CYLD regulates entry into mitosis
Stegmeier, F. P., Sowa, M. E., Nalepa, G., Gygi, S. P., Harper, J. W., & Elledge, S. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703268104 · Cited by 137
Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A
Pereg, Y., Liu, B. Y., O’Rourke, K. M., Sagolla, M. S., Dey, A., Kömüves, L. G., French, D. M., & Dixit, V. M. (2010) · Nature Cell Biology · doi:10.1038/ncb2041 · Cited by 134
An Emerging Model for BAP1’s Role in Regulating Cell Cycle Progression
Eletr, Z. M., & Wilkinson, K. D. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9184-6 · Cited by 133
The USP1/UAF1 Complex Promotes Double-Strand Break Repair through Homologous Recombination
Murai, J., Yang, K., Dejsuphong, D., Hirota, K., Takeda, S., & D’Andrea, A. D. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05058-11 · Cited by 128
The therapeutic potential of deubiquitinating enzyme inhibitors
Colland, F. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380137 · Cited by 127
Gilbert, R. E., Huang, Q., Thai, K., Advani, S. L., Lee, K., Yuen, D. A., Connelly, K. A., & Advani, A. (2011) · Kidney International · doi:10.1038/ki.2011.39 · Cited by 126
Targeting ubiquitin specific proteases for drug discovery
Daviet, L., & Colland, F. (2008) · Biochimie · doi:10.1016/j.biochi.2007.09.013 · Cited by 126
Tran, H., Hamada, F., Schwarz, T., & Bienz, M. (2008) · Genes & Development · doi:10.1101/gad.463208 · Cited by 123
Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of Aurora B
van Leuken, R. J., Luna‐Vargas, M. P. A., Sixma, T. K., et al. (2008) · Cell Cycle · doi:10.4161/cc.7.17.6553 · Cited by 122
Li, Z., Wang, D., Na, X., Schoen, S. R., Messing, E. M., & Wu, G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00534-x · Cited by 122
Parsons, J. L., Dianova, I. I., Khoronenkova, S. V., Edelmann, M. J., Kessler, B. M., & Dianov, G. L. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.016 · Cited by 121
Feng, L., Wang, J., & Chen, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135392 · Cited by 121
McFarlane, C., Kelvin, A. A., de la Vega, M., Govender, U., Scott, C. J., Burrows, J. F., & Johnston, J. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4152 · Cited by 120
Cao, Z., Wu, X., Yen, L., Sweeney, C., & Carraway, K. L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01245-06 · Cited by 119
Deubiquitinating Enzymes are IN(Trinsic to Proteasome Function)
Guterman, A., & Glickman, M. H. (2004) · Current Protein and Peptide Science · doi:10.2174/1389203043379756 · Cited by 115
Xu, G., Tan, X., Wang, H., Sun, W., Shi, Y., Burlingame, S. M., Gu, X. F., Cao, G., Zhang, T., Qin, J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042689 · Cited by 115
Death-From-Cancer Signatures and Stem Cell Contribution to Metastatic Cancer
Glinsky, G. V. (2005) · Cell Cycle · doi:10.4161/cc.4.9.2001 · Cited by 115
Colombo, M., Vallese, S., Peretto, I., Jacq, X., Rain, J., Colland, F., & Guedat, P. (2010) · ChemMedChem · doi:10.1002/cmdc.200900409 · Cited by 113
Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosis
Sun, H., Kapuria, V., Peterson, L. F., Fang, D., Bornmann, W. G., Bartholomeusz, G. A., Talpaz, M., & Donato, N. J. (2011) · Blood · doi:10.1182/blood-2010-03-276477 · Cited by 112
Huang, X., Langelotz, C., Hetfeld, B. K. J., Schwenk, W., & Dubiel, W. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.06.066 · Cited by 109
Synthetic lethal approaches to breast cancer therapy
Rehman, F. L., Lord, C. J., & Ashworth, A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.172 · Cited by 104
Reversible Monoubiquitination Regulates the Parkinson Disease-associated Ubiquitin Hydrolase UCH-L1
Meray, R. K., & Lansbury, P. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611153200 · Cited by 103
A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells
Vendrell, J. A., Ghayad, S. E., Larbi, S. B., Dumontet, C., Mechti, N., & Cohen, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210269 · Cited by 100
The role of deubiquitinating enzymes in apoptosis
Ramakrishna, S., Suresh, B., & Baek, K. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0504-6 · Cited by 99
Yu, L., Adegoke, O. A. J., Nepveu, A., Nakayama, K. I., Bedard, N., Cheng, D., Peng, J., & Wing, S. S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00329-08 · Cited by 99
DUB-3, a Cytokine-inducible Deubiquitinating Enzyme That Blocks Proliferation*
Burrows, J. F., McGrattan, M. J., Rascle, A., Humbert, M., Baek, K., & Johnston, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311291200 · Cited by 97
An Atlas of Altered Expression of Deubiquitinating Enzymes in Human Cancer
Luise, C., Capra, M. C., Donzelli, M., Mazzarol, G., Jodice, M. G., Nuciforo, P. G., Viale, G., Fiore, P. P. D., & Confalonieri, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015891 · Cited by 97
Mullally, J. E., & Fitzpatrick, F. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.351 · Cited by 97
The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway
Zhao, B., Schlesiger, C., Masucci, M. G., & Lindsten, K. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00682.x · Cited by 95
Elevated expression of Unph, a proto-oncogene at 3p21.3, in human lung tumors
Gray, D. A. (1995) · Lung Cancer · doi:10.1016/0169-5002(96)84243-7 · Cited by 92
Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36
Endo, A., Matsumoto, M., Inada, T., Yamamoto, A., Nakayama, K. I., Kitamura, N., & Komada, M. (2009) · Journal of Cell Science · doi:10.1242/jcs.044461 · Cited by 90
The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation
Li, L., Soetandyo, N., Wang, Q., & Ye, Y. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.09.013 · Cited by 86
The role of deubiquitinating enzymes in chromatin regulation
Atanassov, B. S., Koutelou, E., & Dent, S. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.042 · Cited by 85
Chen, M., Gutierrez, G. J., & Ronai, Z. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100028108 · Cited by 84
Kessler, B. M., & Edelmann, M. J. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9176-6 · Cited by 84
UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction
Jang, M. J., Baek, S. H., & Kim, J. H. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.006 · Cited by 84
Patented small molecule inhibitors in the ubiquitin proteasome system
Guédat, P., & Colland, F. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s14 · Cited by 83
The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis
Kuhlbrodt, K., Janiesch, P. C., Kevei, É., Segref, A., Barikbin, R., & Hoppe, T. (2011) · Nature Cell Biology · doi:10.1038/ncb2200 · Cited by 82
CYLD mutations in familial skin appendage tumours
Saggar, S., Chernoff, K. A., Lodha, S., Horev, L., Kohl, S., Honjo, R. S., Brandt, H. R. C., Hartmann, K., & Çelebi, J. T. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.056127 · Cited by 82
CYLD regulates angiogenesis by mediating vascular endothelial cell migration
Gao, J., Sun, L., Huo, L., Liu, M., Li, D., & Zhou, J. (2010) · Blood · doi:10.1182/blood-2009-10-248526 · Cited by 80
Tian, X., Isamiddinova, N. S., Peroutka, R. J., Goldenberg, S. J., Mattern, M. R., Nicholson, B., & Leach, C. (2011) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2010.0317 · Cited by 76
González-Navajas, J. M., Law, J. K., Nguyen, K. P., Bhargava, M., Corr, M., Varki, N. M., Eckmann, L., Hoffman, H. M., Lee, J., & Raz, E. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101326 · Cited by 74
Duex, J. E., Comeau, L., Sorkin, A. D., Purow, B. W., & Kefas, B. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.222760 · Cited by 72
USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation
Guervilly, J.-H., Renaud, E., Takata, M., & Rosselli, F. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr103 · Cited by 72
CSN5 Isopeptidase Activity Links COP9 Signalosome Activation to Breast Cancer Progression
Adler, A. S., Littlepage, L. E., Lin, M., Kawahara, T. L. A., Wong, D. J., Werb, Z., & Chang, H. Y. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3060 · Cited by 72
High incidence of ubiquitin‐like domains in human ubiquitin‐specific proteases
Zhu, X., Menard, R., & Sulea, T. I. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21546 · Cited by 68
Yamaguchi, T., Kimura, J., Miki, Y., & Yoshida, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706282200 · Cited by 66
The Unp proto-oncogene encodes a nuclear protein.
Gupta, K., Chevrette, M., & Gray, D. A. (1994) · PubMed · Cited by 66
USP15 plays an essential role for caspase-3 activation during Paclitaxel-induced apoptosis
Xu, M., Takanashi, M., Oikawa, K., Tanaka, M., Nishi, H., Isaka, K., Kudo, M., & Kuroda, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.015 · Cited by 63
Enesa, K., Ito, K., Luong, L. A., Thorbjornsen, I., Phua, C., To, Y., Dean, J. L. E., Haskard, D. O., Boyle, J., Adcock, I. M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801312200 · Cited by 61
An RNAi screen identifies USP2 as a factor required for TNF‐α‐induced NF‐κB signaling
Metzig, M. O., Nickles, D., Falschlehner, C., Lehmann‐Koch, J., Straub, B. K., Roth, W., & Boutros, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26124 · Cited by 59
Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours
Rajan, N., Elliott, R. J. R., Clewes, O., Mackay, A. G., Reis-Filho, J. S., Burn, J., Langtry, J. A. A., Sieber‐Blum, M., Lord, C. J., & Ashworth, A. (2011) · Oncogene · doi:10.1038/onc.2011.133 · Cited by 58
Zhang, C., Cai, T., Zhu, H., Yang, L., Jiang, H., Dong, X., Hu, Y., Lin, N.-M., He, Q., & Yang, B. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1091 · Cited by 58
Regulation of ErbB2 Receptor Status by the Proteasomal DUB POH1
Liu, H., Buus, R., Clague, M. J., & Urbé, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005544 · Cited by 50
Aressy, B., Jullien, D., Cazalès, M., Marcellin, M., Bugler, B., Burlet‐Schiltz, O., & Ducommun, B. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13133 · Cited by 48
Baek, K., Kim, M., Kim, Y., Shin, J. A., & Choi, H.-K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m304774200 · Cited by 45
Oh, K. H., Yang, S. W., Park, J. M., Seol, J. H., Iemura, S.-I., Natsume, T., Murata, S., Tanaka, K., Jeon, Y. J., & Chung, C. H. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.3 · Cited by 45
Cytokine-Regulated Protein Degradation by the Ubiquitination System
Baek, K. (2006) · Current Protein and Peptide Science · doi:10.2174/138920306776359740 · Cited by 44
Schulze-Bergkamen (2010) · International Journal of Oncology · doi:10.3892/ijo_00000831 · Cited by 44
Ibarrola, N., Kratchmarova, I., Nakajima, D., Schiemann, W. P., Moustakas, A., Pandey, A., & Mann, M. (2004) · BMC Cell Biology · doi:10.1186/1471-2121-5-2 · Cited by 42
CSN5/Jab1 controls multiple events in the mammalian cell cycle
Yoshida, A., Yoneda‐Kato, N., Panattoni, M., Pardi, R., & Kato, J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.039 · Cited by 35
Yu, L., Bedard, N., Chevalier, S., & Wing, S. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015936 · Cited by 35
Lys-63-specific Deubiquitination of SDS3 by USP17 Regulates HDAC Activity
Ramakrishna, S., Suresh, B., Lee, E.-J., Lee, H.-J., Ahn, W., & Baek, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162321 · Cited by 35
Deubiquitinating enzyme USP36 contains the PEST motif and is polyubiquitinated
Kim, M., Kim, Y., Kim, Y., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.051 · Cited by 31
HAUSP, a deubiquitinating enzyme for p53, is polyubiquitinated, polyneddylated, and dimerized
Lee, H., Kim, M., Kim, Y., Oh, Y., & Baek, K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.07.048 · Cited by 30
Ataxin‐3 is subject to autolytic cleavage
Mauri, P., Riva, M., Ambu, D., Palma, A. D., Secundo, F., Benazzi, L., Valtorta, M., Tortora, P., & Fusi, P. A. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05419.x · Cited by 29
Protease Addiction and Synthetic Lethality in Cancer
Freije, J., Fraile, J. M., & López-Otı́n, C. (2011) · Frontiers in Oncology · doi:10.3389/fonc.2011.00025 · Cited by 22
Self-citationDeciphering histone 2A deubiquitination
Clague, M. J., Coulson, J. M., & Urbé, S. (2008) · Genome biology · doi:10.1186/gb-2008-9-1-202 · Cited by 20
Jaster, R., Baek, K., & D’Andrea, A. D. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00095-0 · Cited by 10
Cited by
Ubiquitination in disease pathogenesis and treatment
Popovic, D., Vucic, D., & Dikic, I. (2014) · Nature Medicine · doi:10.1038/nm.3739 · Cited by 1,401
Báez-Santos, Y. M., St. John, S. E., & Mesecar, A. D. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.015 · Cited by 854
Regulation of DNA Damage Responses by Ubiquitin and SUMO
Jackson, S. P., & Durocher, D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.017 · Cited by 601
Bertrand, B., & Casini, A. (2014) · Dalton Trans. · doi:10.1039/c3dt52524d · Cited by 441
Advances in Targeting ‘Undruggable’ transcription Factors With Small Molecules
Henley, M. J., & Koehler, A. N. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00199-0 · Cited by 409
Metadata
- Authors
- Fraile, J. M., Quesada, V, Rodríguez, D., Freije, J. M. P., & López-Otín, C.
- Venue
- Oncogene
- Published
- 2011-09-26
- Volume
- 31
- Issue
- 19
- Pages
- 2373-2388
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2088767253
- Cited by
- 453
- References
- 200
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.